Merck Serono: All Eyes On China
This article was originally published in PharmAsia News
Executive Summary
Merck Serono is planning to invest €80 million to build up a major new manufacturing site in Nantong, which will initially produce three products on the essential drug list. The company has also held the first overseas meeting of its executive board in Shanghai, which reflects the company’s ambitions in the country.